These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18379181)

  • 1. [Population pharmacokinetic analysis of two theophylline formulations in premature neonates and infants with apnea].
    Suda Y; Hanada K; Tsuchiwata S; Saito M; Nakamura T; Ito Y; Ishikawa Y; Kushida K; Ogata H
    Yakugaku Zasshi; 2008 Apr; 128(4):635-40. PubMed ID: 18379181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea.
    Fukuda T; Yukawa E; Kondo G; Maeda T; Shin-o T; Kondo Y; Imamura T; Irikura M; Irie T
    J Clin Pharm Ther; 2005 Dec; 30(6):591-6. PubMed ID: 16336292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theophylline concentration following equal doses of intravenous aminophylline and oral theophylline in preterm infants.
    al-Omran A; al-Alaiyan S
    Am J Perinatol; 1997 Mar; 14(3):147-9. PubMed ID: 9259917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of theophylline in premature neonates during the first few days after birth.
    du Preez MJ; Botha JH; McFadyen ML; Holford NH
    Ther Drug Monit; 1999 Dec; 21(6):598-603. PubMed ID: 10604818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of theophylline in preterm neonates during the first month of life.
    Islam SI; Ali AS; Sheikh AA; Fida NM
    Saudi Med J; 2004 Apr; 25(4):459-65. PubMed ID: 15083216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of theophylline in premature Korean infants.
    Kim SE; Kim BH; Lee S; Sohn JA; Kim HS; Cho JY; Yoon SH; Jang IJ; Yu KS; Lim KS
    Ther Drug Monit; 2013 Jun; 35(3):338-44. PubMed ID: 23666573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
    Bach JE; Kukanich B; Papich MG; McKiernan BC
    J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline population pharmacokinetics from routine monitoring data in very premature infants with apnoea.
    Lee TC; Charles BG; Steer PA; Flenady VJ; Grant TC
    Br J Clin Pharmacol; 1996 Mar; 41(3):191-200. PubMed ID: 8866918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs.
    Björkman S
    Br J Clin Pharmacol; 2005 Jun; 59(6):691-704. PubMed ID: 15948934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The disposition of theophylline in camels after intravenous administration.
    Wasfi IA; Elghazali M; Boni NS; Hadi AA; Alhadrami GA; Almuhrami AM; Alkatheeri NA; Barezaiq IM; Agha BA; Wajid SA
    J Vet Pharmacol Ther; 1999 Aug; 22(4):255-60. PubMed ID: 10499237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.
    Sohn JA; Kim HS; Oh J; Cho JY; Yu KS; Lee J; Shin SH; Lee JA; Choi CW; Kim EK; Kim BI; Park EA
    Br J Clin Pharmacol; 2017 Jun; 83(6):1279-1286. PubMed ID: 27995649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the theophylline pharmacokinetics of sustained-release theophylline (Theodur) dry syrup in children].
    Okuma M; Iikura Y
    Arerugi; 1999 Jun; 48(6):589-96. PubMed ID: 10423899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of a modified, compounded theophylline product in dogs.
    Cavett CL; Li Z; McKiernan BC; Reinhart JM
    J Vet Pharmacol Ther; 2019 Nov; 42(6):593-601. PubMed ID: 31529628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline toxicokinetics in premature newborns.
    Lowry JA; Jarrett RV; Wasserman G; Pettett G; Kauffman RE
    Arch Pediatr Adolesc Med; 2001 Aug; 155(8):934-9. PubMed ID: 11483122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The population pharmacokinetics of theophylline in neonates and young infants.
    Moore ES; Faix RG; Banagale RC; Grasela TH
    J Pharmacokinet Biopharm; 1989 Feb; 17(1):47-66. PubMed ID: 2715932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrofloxacin-theophylline interaction: influence of enrofloxacin on theophylline steady-state pharmacokinetics in the beagle dog.
    Intorre L; Mengozzi G; Maccheroni M; Bertini S; Soldani G
    J Vet Pharmacol Ther; 1995 Oct; 18(5):352-6. PubMed ID: 8587153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline pharmacokinetics in premature infants with apnea.
    Giacoia G; Jusko WJ; Menke J; Koup JR
    J Pediatr; 1976 Nov; 89(5):829-32. PubMed ID: 789845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age- and Bodyweight-dependent Allometric Exponent Model for Scaling Clearance and Maintenance Dose of Theophylline From Neonates to Adults.
    Tegenge MA; Mahmood I
    Ther Drug Monit; 2018 Oct; 40(5):635-641. PubMed ID: 30086085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.